![Martin Bott](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Martin Bott served as the VP-Corporate Finance & Investment Banking at Eli Lilly & Co. from 2015 to 2017.
He also served as an Independent Director at InMed Pharmaceuticals, Inc. from 2017 to 2019 and as a Director at CoLucid Pharmaceuticals, Inc. Additionally, he received an undergraduate degree from Universität zu Köln in 1985 and a graduate degree from the University of South Carolina in 1988.
Anciens postes connus de Martin Bott
| Sociétés | Poste | Fin |
|---|---|---|
| INMED PHARMACEUTICALS INC. | Directeur/Membre du Conseil | 31/08/2019 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/12/2017 |
| COLUCID PHARMACEUTICALS INC | Directeur/Membre du Conseil | - |
Formation de Martin Bott
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
92
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
InMed Pharmaceuticals, Inc.
 InMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures prescription-based products for dermatology and ocular diseases | Health Technology |
CoLucid Pharmaceuticals, Inc.
 CoLucid Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurological disorders | Health Technology |
Universität zu Köln
 Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of South Carolina
 University of South Carolina Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
